Lack of Association between Thrombosis in Primary Antiphospholipid Syndrome and the Recently Described Thrombophilic 3’-untranslated Prothombin Gene Polymorphism

• 1 Sebastiani GD, Galeazzi M. Immunogenetics of the antiphospholipid syndrome. In: The antiphospholipid syndrome. Asherson RA, Cervera R, Piette JC, Shoenfeld Y. eds CRC Press; Boca Raton, PA: 1996. pp 49-58
• 2 Finazzi G, Brancaccio V, Moia M, Ciavarella M, Mazzucconi G, Schinco PC, Ruggeri M, Pogliani EM, Gamba G, Rossi E, Baudo F, Manotti C, D’Angelo A, Palareti G, De StefanoV, Berrettini M, Barbui T. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian registry. Am J Med 1996; 100: 530-536
• 3 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703
• 4 Piette JC. 1996 Diagnostic and classification criteria for the antiphospholipid/cofactor syndrome: a »mission impossible«?. Lupus 1996; 5: 354-363
• 5 Biousse V, Piette JC, Francès C, Bletry O, Papo T, Toumier-Laserve E, Duchemin J, Aiach M. Primary antiphospholipid syndrome is not associated with APC resistance caused by factor V Arg→Gln mutation. Rheumatol 1995; 22: 1215
• 6 Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-1457
• 7 Koeleman BPC, Rumpt D, Hamulyak K, Reitsma PH, Bertina RM. Factor V Leiden: An additional risk for thrombosis in protein S deficient families?. Thromb Haemost 1995; 74: 580-583